← Open Payments lookup

ANDREA MOSCHOPOULOS: Open Payments

NPI 1326749730 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,644 in 175 payments from 16 companies in 2025. Trend: 2023 $1,401 · 2024 $2,990 · 2025 $3,644

Food & beverage: $3,644
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)35$899
Neurocrine BioSciences, Inc.17$571
Otsuka America Pharmaceutical, Inc.33$512
Axsome Therapeutics, Inc.16$250
Collegium Pharmaceutical, Inc.14$215
Takeda Pharmaceuticals U.S.A., Inc.7$183
Lundbeck LLC9$178
E.R. Squibb & Sons, L.L.C.7$173
Teva Pharmaceuticals USA, Inc.10$161
Vanda Pharmaceuticals Inc.7$159

Products named: CAPLYTA, REXULTI, INGREZZA, Auvelity, Jornay PM, TRINTELLIX, COBENFY, FANAPT.

Industry payments across MA — which companies pay providers there.